We looked studied the connection between CTL levels and OS of patients in various groups with varying expression levels of the Trx system in lung cancer in order to better understand whether there is a clinical correlation between abnormal expression of Trx system and T cell dysfunction. This evidence concerns the gene TXN and lung cancer.